Latest podcast: Cardiometabolic Rx: Part 2: Interventions and innovations
Date
18 Nov 2025
Author/Presenter
Share
Table of Contents
Summary
In part two of our Perspectives podcast, fx Medicine by BioCeuticals ambassadors Lisa Costa-Bir, Dr Michelle Woolhouse, Mick Alexander and Dr Adrian Lopresti join host Emma Sutherland to explore practical, evidence-aligned treatment strategies for patients with cardiometabolic dysfunction.
The discussion covers GLP-1 receptor agonists (GLP-1 RAs) including side effect management and dietary and lifestyle support. They also discuss the evolving landscape of new cardiometabolic medications, and the behavioural, psychological, and social factors that shape long-term cardiometabolic outcomes.
The ambassadors break down current evidence, share their clinic insights from their own practice, and examine how practitioners can better support patients through complementary medicine use, behavioural change, and sustained diet and lifestyle modification. A detailed case study illustrates multidisciplinary reasoning across naturopathy, psychology, pharmacy and general practice, highlighting how small, achievable steps can create meaningful momentum for complex patients.
This episode gives practitioners a comprehensive and compassionate roadmap for supporting sustainable cardiometabolic change in everyday clinical practice.